EFX vs VYGR · P/E 54, rev $5.68B vs rev $80.0M
Equifax Inc (EFX) versus Voyager Therapeutics Inc (VYGR) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported VYGR revenue for 2024-12-31 was $80.0M. Net income was -$65.0M. Revenue was down 68.0% from 2023-12-31 to 2024-12-31. VYGR currently screens at market cap $225.4M.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. VYGR currently screens at market cap $225.4M.
Not investment advice. Open the EFX and VYGR stock pages for the full models.
Not investment advice.